The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds

Title
The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds
Authors
Keywords
Chiral drugs, Chiral switch, Enantioselective chromatography, Single-enantiomer drugs, Racemates, Enantiomeric excess determination
Journal
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume 147, Issue -, Pages 323-340
Publisher
Elsevier BV
Online
2017-07-11
DOI
10.1016/j.jpba.2017.07.008

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started